|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/165 | |
| A61K 38/21 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2451449 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10731897.4 |
| Europos patento paraiškos padavimo data | 2010-07-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-05-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-05-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/041274 |
| Data | 2010-07-08 |
| (87) | Numeris | WO 2011/005907 |
| Data | 2011-01-13 |
| (30) | Numeris | Data | Šalis |
| 09305669 | 2009-07-10 | EP | |
| 225342 P | 2009-07-14 | US | |
| 286148 P | 2009-12-14 | US | |
| 350957 P | 2010-06-03 | US |
| (72) |
BYRNES, William, US
DOUILLET, Patrice, FR
FRANGIN, Gerald, FR
|
| (73) |
Sanofi-Aventis U.S. LLC,
55 Corporate Drive, Bridgewater, NJ 08807,
US
|
| (54) | USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS |
| USE OF THE COMBINATION OF TERIFLUNOMIDE AND INTERFERON BETA FOR TREATING MULTIPLE SCLEROSIS |